How to Navigate Uncertainty and Transformation in 2025

Lisa Delfini has served as Chief Financial Officer of Trevi Therapeutics since August 2021. Ms. Delfini served as a Financial Accounting and Advisory Services Partner at Marcum LLP, an accounting and advisory services company, from 2015 until August 2021, specializing in providing services to companies in the life science and high-tech industries. Previously, she worked at General Electric Company, a multinational conglomerate, as Global Controller for the GE Corporate Technical Center of Excellence from 2011 to 2014 and as Global Controller for the GE Industrial Solutions division from 2014 to 2015. Ms. Delfini began her career at Deloitte & Touche LLP, where she worked for 16 years, completing her time there as a Client Service Partner. Ms. Delfini received a B.S. in accounting from Lehigh University and is a Certified Public Accountant licensed by the state of Connecticut.

Erin Warner Guill is the President and COO of Auxilius, where she leads go-to-market and customer success efforts for the company’s end-to-end clinical trial financial management platform. She brings deep experience at the intersection of biotechnology, finance, and operations, including a background in investment banking and strategic advisory for high-growth life sciences companies. Erin is passionate about helping biopharma finance teams gain clarity and control in an increasingly complex R&D environment.